more_reports

Zymeworks Inc.

ZYME:NYSE; ZYME:TSX

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. The company's suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates.

streetwise book logo Streetwise Company Fact Sheet

2024/12/27 10:20:24

(ZYME:NYSE - ZYME:TSX)

Analyst coverage

Wells Fargo & Co. — Derek Achila
H.C. Wainwright & Co. — Robert Burns
J.P. Morgan — Brian Cheng
Bloom Burton & Co. — David Martin
Evercore — Jon Miller
Citi — Yigal Nochomovitz
H.C. Wainwright & Co. — Dr. Ram Selvaraju
Jefferies & Co. — Akash Tewari
Stifel — Stephen Willey

Streetwise Reports Articles

09/25/2024 - View Article